Further specification of the terminology can be achieved by including the target of the employed radioligand, such as “metabolic connectivity/covariance” for [18F]FDG or “amyloid covariance” for [18F]flutemetamol and “tau covariance” for [18F]flortaucipir. This evidence concerns the gene MAPT and amyloidosis.